- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Oxygenta Pharmaceutical Ltd — Board Meeting, 04-02-2026: Board Meeting
04-02-2026 | 06:02 pm
04-02-2026 | 06:02 pm
Oxygenta Pharma's board has approved Q3 and nine-month financial results. Q3 Net Sales reached ₹3.39 Cr, while the Net Loss significantly narrowed to ₹0.84 Cr from ₹3.93 Cr in the prior year quarter.
No comments yet. Be the first to comment!